Two Brain Inhibitors Inhibit Renal Na,K-ATPases without Recognizing the Species-Dependent Variation of Their Ouabain-Sensitivity

References

• Jorgensen P. L. Isolation of (Na + K)-ATPase. Methods Enzymol. 1974; 32: 277–290
   PubMedGoogle Scholar
• Schwartz A., Lindenmayer G. E., Allen J. C. The Na+,K+-ATPase membrane transport system: importance in cellular function Curr Top. Membrane Transp. 1972; 3: 2–80
   Google Scholar
• Schatzmann H.-J. Herzglykoside als Hemmstoffe für den aktiven Kalium- und Natriumtransport durch die Erythrocytenmembran Helv Physiol Acta. 1953; 11: 346–354
   Google Scholar
• Glynn I. M. The action of cardiac glycosides on ion movements Pharmacol Rev. 1964; 16: 381–407
   Google Scholar
• Hansen O. Interaction of cardiac glycosides with (Na++K+)-activated ATPase. A biochemical link to digitalis-induced inotropy. Pharmacol Rev. 1984; 36: 143–163
   Google Scholar
• Goldin S. M., Tong S. W. J Biol Chem. 1974; 249: 5907–5915
   PubMed Web of Science ®Google Scholar
• Jorgensen P. L. Mechanism of the Na,K-pump. Protein structure and conformations of the pure (Na + K)-ATPase. Biochim Biophys Acta. 1982; 694: 27–69
   PubMed Web of Science ®Google Scholar
• Gonick H. C., Kramer H. J., Paul W., Lu E. Circulating inhibitor of sodium-potassium-activated adenosine-trisphosphatase after expansion of extracellular fluid volume in rats. Clin Sci Mol Med 1977; 53: 329–334
   PubMedGoogle Scholar
• Flier J. S. Ouabain-like activity in toad skin and its implication for endogenous regulation of ion transport. Nature 1978; 274: 285–286
   PubMed Web of Science ®Google Scholar
• Buckalew V. M., Gruber K. A. Natriuretic hormone. Ann Rev Physiol. 1984; 46: 343–358
   PubMed Web of Science ®Google Scholar
• Blaustein M. P., Hamlyn J. M. Sodium transport inhibition, cell calcium and hypertension. The natriuretic hormone/ Na-Ca exchange/ hypertension hypothesis. Am J Med. 1984; Oct. 5: 45–59
   Google Scholar
• De Wardener H. E., Clarkson E. M. Concepts of natriuretic hormones. Physiol Rev. 1985; 65: 658–759
   PubMed Web of Science ®Google Scholar
• Haber E., Haupert G. T. The search for a hypothalamic Na,K-ATPase inhibitor. Hypertension 1987; 9: 315–324
   PubMed Web of Science ®Google Scholar
• Haddy F. J. Natriuretic hormone. N Engl J Med. 1987; 316: 621–623
   PubMed Web of Science ®Google Scholar
• Goto A., Yamada K., Yagi N., Yoshioka M., Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev. 1992; 44: 377–395
   PubMed Web of Science ®Google Scholar
• Hamlyn J. M., Blaustein M. P., Bova S., DuCharme D. W., Harris D. W., Mandel F., Mathews W. R., Ludens J. H. Identification and characterization of a ouabain-like compound from human plasma Proc Natl Acad Sci USA. 1991; 88: 6259–6263
   PubMed Web of Science ®Google Scholar
• Tymiak A. A, Norman J. A., Bolgar M., DiDonato G. C., Lee H., Parker W. L., Lo L.-C., Berova N, Nakanishi K, Haber E, Haupert G. T., Jr. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci. 1993; 90: 8189–8193
   PubMed Web of Science ®Google Scholar
• Ferrandi M., Minotti E., Salardi S., Florio M., Bianchi G., Ferrari P. The ouabain-like factor in the Milan hypertensive rats. Am J Physiol. 1992; 263: F739–F784
   Google Scholar
• Wechter W. J., Benaksas E. Natriuretic hormones. Progr Drug Res. 1990; 34: 231–260
   PubMedGoogle Scholar
• Blaustein M. P. Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. Am J Physiol. 1993; 264: C1367–C1387
   PubMed Web of Science ®Google Scholar
• Lichtstein D., Samuelov S., Gati I., Wechter W. J. Digitalis-like compounds in animal tissue. J Bas Clin Physiol Pharmacol. 1992; 3: 269–292
   Google Scholar
• Anner B. M., Rey H. G., Moosmayer M., Meszoely I., Haupert G. T., Jr. Hypothalamic Na,K-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na,K-ATPase. Am J Physiol 1990; 258: F144–F153
   PubMed Web of Science ®Google Scholar
• Illescas M., Ricote M., G-Robles R., Sancho J. Complete purification of two identical Na+-pump inhibitors isolated from hypothalamus and hypophysis. FEBS 1990; 261: 436–440
   PubMed Web of Science ®Google Scholar
• Rodriguez-Barbero A., Martinez-Salgado C., Rodriguez-Lopez A., Ricote M., Sancho J., Lopez-Novoa J. M. Effect of hyopthalamic-hypophysary inhibitory factor on mesangial cell activation. Hypertension 1995; 26: 905–911
   PubMed Web of Science ®Google Scholar
• Zhao N., Lo L-Ch., Berova N., Nakanishi K., Tymiak A., Ludens J., Haupert G. T., Jr. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochem. 1995; 34: 9893–9896
   PubMed Web of Science ®Google Scholar
• Dzhandzhugazyan K. N., Jørgensen P. L. Asymmetric orientation of amino groups in the -subunit and the -subunit of (Na+ +K+)- ATPase in tight right-side-out vesicles of basolateral membranes from outer medulla. Biochim Biophys Acta. 1985; 817: 165–173
   PubMed Web of Science ®Google Scholar
• Anner B. M., Moosmayer M., Imesch E. Mercury blocks Na,K-ATPase by a ligand-dependent and reversible mechanism. Am J Physiol. 1992; 262: F830–F836.$
   PubMed Web of Science ®Google Scholar
• Sweadner K. J. Isozymes of Na+/K+-ATPase. Biochim Biophys Acta. 1989; 988: 185–220
   PubMed Web of Science ®Google Scholar
• Repke K., Est M., Portius H. J. Ueber die Ursache der Speziesunterschiede in der Digitalisempfindlichkeit. Biochem Pharmacol. 1965; 14: 1785–1802
   PubMedGoogle Scholar
• Detweiler D. K. Comparative pharmacology of cardiac glycosides Fed Proc. 1967; 26: 1119–1126
   Google Scholar
• Jewell E. A., Lingrel J. B. Comparison of the substrate dependence properties of the rat Na,K-ATPase 1, 2, and 3 isoforms expressed in HeLa cells. J Biol Chem 1991; 266: 16925–16930
   PubMed Web of Science ®Google Scholar